FDA Concerned About Study On Risks Of Chantix
U.S. Food and Drug Administration staff voiced concerns with a how study handled adverse events on Monday in advance of a meeting to consider whether or not a black box warning...To view the full article, register now.
Already a subscriber? Click here to view full article